SCF PHARMA INC.
12Patents
12Active
12Granted
53Portfolio score
Filing activity: Apr 30, 2012 → May 19, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8722737B2 | Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US9101563B2 | Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8816110B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9447020B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9233915B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9480660B2 | Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10716776B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | Human Necessities | 4 | Active |
| US9925165B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US11166933B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12226390B2 | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof | Human Necessities | 0 | Active |
| US11701337B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | Human Necessities | 0 | Active |
| US11478443B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.